1.
Ten years countdown to hepatitis C elimination in Belgium : a mathematical modeling approach
2.
Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
3.
4.
5.
6.
7.
8.
9.
Analyses of clinical and biological data for French and Belgian immunocompetent patients infected with hepatitis E virus genotypes 4 and 3
Table_1_Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3.XLSX
Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3
Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3.
Using an audit tool (MAPS Global) to assess the characteristics of the physical environment related to walking for transport in youth : reliability of Belgian data
Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results.
Multicenter Belgian experience of sofosbuvir medical need program in pre-and post-liver transplantation patients: safety and efficacy results.
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up